A detailed history of Deutsche Bank Ag\ transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 169,301 shares of PACB stock, worth $330,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
169,301
Previous 117,745 43.79%
Holding current value
$330,136
Previous $161,000 78.26%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.2 - $2.17 $61,867 - $111,876
51,556 Added 43.79%
169,301 $287,000
Q2 2024

Aug 14, 2024

SELL
$1.36 - $3.65 $68,363 - $183,474
-50,267 Reduced 29.92%
117,745 $161,000
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $32,612 - $88,851
9,265 Added 5.84%
168,012 $630,000
Q4 2023

Feb 14, 2024

SELL
$5.97 - $10.36 $5,659 - $9,821
-948 Reduced 0.59%
158,747 $1.56 Million
Q3 2023

Nov 09, 2023

SELL
$8.23 - $13.93 $15,974 - $27,038
-1,941 Reduced 1.2%
159,695 $1.33 Million
Q2 2023

Aug 14, 2023

SELL
$9.97 - $14.05 $494,402 - $696,725
-49,589 Reduced 23.48%
161,636 $2.15 Million
Q1 2023

May 15, 2023

SELL
$7.94 - $12.02 $116,289 - $176,044
-14,646 Reduced 6.48%
211,225 $2.45 Million
Q4 2022

Feb 13, 2023

SELL
$5.67 - $11.2 $197,247 - $389,625
-34,788 Reduced 13.35%
225,871 $1.85 Million
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $152,535 - $332,627
-38,813 Reduced 12.96%
260,659 $1.51 Million
Q2 2022

Aug 11, 2022

SELL
$4.02 - $10.43 $11,372 - $29,506
-2,829 Reduced 0.94%
299,472 $1.32 Million
Q1 2022

May 13, 2022

SELL
$8.43 - $20.9 $185,400 - $459,653
-21,993 Reduced 6.78%
302,301 $2.75 Million
Q4 2021

Feb 11, 2022

SELL
$19.26 - $30.08 $1.26 Million - $1.96 Million
-65,213 Reduced 16.74%
324,294 $6.64 Million
Q3 2021

Nov 04, 2021

BUY
$24.86 - $35.02 $1.34 Million - $1.89 Million
53,869 Added 16.05%
389,507 $9.95 Million
Q2 2021

Aug 11, 2021

BUY
$22.3 - $36.02 $3.51 Million - $5.67 Million
157,492 Added 88.41%
335,638 $11.7 Million
Q1 2021

May 13, 2021

SELL
$26.38 - $51.15 $264,881 - $513,597
-10,041 Reduced 5.34%
178,146 $5.93 Million
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $302,557 - $821,227
28,815 Added 18.08%
188,187 $4.88 Million
Q3 2020

Nov 12, 2020

SELL
$3.61 - $9.87 $308,351 - $843,055
-85,416 Reduced 34.89%
159,372 $1.57 Million
Q2 2020

Aug 13, 2020

BUY
$2.65 - $4.03 $459,046 - $698,096
173,225 Added 242.06%
244,788 $845,000
Q1 2020

May 14, 2020

BUY
$2.36 - $5.26 $17,695 - $39,439
7,498 Added 11.7%
71,563 $219,000
Q4 2019

Feb 14, 2020

BUY
$4.6 - $5.57 $53,534 - $64,823
11,638 Added 22.2%
64,065 $329,000
Q3 2019

Nov 14, 2019

SELL
$4.99 - $6.16 $335,328 - $413,952
-67,200 Reduced 56.17%
52,427 $270,000
Q2 2019

Aug 14, 2019

SELL
$5.92 - $7.41 $1.87 Million - $2.34 Million
-316,323 Reduced 72.56%
119,627 $722,000
Q1 2019

May 15, 2019

SELL
$6.8 - $7.4 $534,235 - $581,373
-78,564 Reduced 15.27%
435,950 $3.15 Million
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $192,928 - $378,120
48,353 Added 10.37%
514,514 $3.81 Million
Q3 2018

Dec 21, 2021

BUY
$3.52 - $5.55 $179,389 - $282,844
50,963 Added 12.27%
466,161 $2.52 Million
Q3 2018

Nov 14, 2018

BUY
$3.52 - $5.55 $188,844 - $297,751
53,649 Added 14.84%
415,198 $2.25 Million
Q2 2018

Apr 21, 2020

BUY
$2.11 - $3.92 $130,212 - $241,911
61,712 Added 20.58%
361,549 $1.28 Million
Q2 2018

Aug 14, 2018

BUY
$2.11 - $3.92 $47,734 - $88,682
22,623 Added 8.16%
299,837 $1.06 Million
Q1 2018

Oct 18, 2019

BUY
$2.05 - $3.23 $129,539 - $204,103
63,190 Added 29.52%
277,214 $567,000
Q1 2018

May 15, 2018

SELL
$2.05 - $3.23 $440,657 - $694,304
-214,955 Reduced 50.11%
214,024 $437,000
Q4 2017

Feb 14, 2018

BUY
$2.59 - $5.44 $517,267 - $1.09 Million
199,717 Added 87.11%
428,979 $1.13 Million
Q3 2017

Nov 14, 2017

BUY
$3.2 - $5.57 $733,638 - $1.28 Million
229,262
229,262 $1.2 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.